Assessment of Venous Return During Volume Expansion: a Prospective Observational Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversità Politecnica delle Marche

About this trial

According to Guyton's model of venous return, the fluids that effectively increase cardiac output are those that, once administered, increase the vascular stressed volume, thereby increasing the mean systemic filling pressure (Pms) without increasing the central venous pressure (CVP). In this way, since the gradient between Pms and CVP increases, venous return-and consequently cardiac output-also increases.

In cases where physiologically ineffective fluids are administered, the situation arises in which, in addition to increasing the stressed volume and thus Pms, CVP also increases. As a result, the gradient between Pms and CVP remains unchanged, and cardiac output does not increase.

The hypothesis is that only a portion of the fluids administered during volume expansion are actually effective in increasing the gradient between Pms and CVP.

Eligibility criteria

Qualifiers

Critically ill patients admitted to the intensive care unit

Invasive or minimally invasive hemodynamic monitoring

Clinical indication for volume expansion with 500 mL of crystalloids

Disqualifiers

Suspected or confirmed pregnancy

Severe aortic stenosis or regurgitation

Severe mitral stenosis or regurgitation

History of peripheral arterial disease

Trial design

Treatments tested in this trial

  • Fluid challenge of 500ml of crystalloid

Treatment groups

No treatment groups listed